Adipose tissue dysfunction leads to abnormal lipid metabolism and high inflammation levels. This research aims to explore the role of Serpina3c, which is highly expressed in adipocytes, in obesity-related hypertriglyceridemia and metaflammation. Serpina3c global knockout (KO) mice, adipocyte-specific Serpina3c overexpressing mice, Serpina3c knockdown (KD) mice, and hypoxia-inducible factor 1 alpha (Hif1α) KD mice were fed a high-fat diet (HFD) for 16 weeks to generate obesity-related hypertriglyceridemia mice models. In the present study, Serpina3c KO mice and adipocyte-specific Serpina3c KD mice exhibited more severe obesity-related hypertriglyceridemia and metaflammation under HFD conditions. Serpina3c KO epididymal white adipose tissue (eWAT) primary stromal vascular fraction (SVF)-derived adipocytes exhibited higher lipid (triglyceride and non-esterified fatty acid) levels and higher fatty acid synthase expression after palmitic acid stimulation. Adipocyte-specific Serpina3c overexpression in KO mice prevented the KO group phenotype. The RNA-seq and in vitro validation revealed that Hif1α and the glycolysis pathways were upregulated in Serpina3c KD adipocytes, which were all validated by in vitro and in vivo reverse experiments. Co-immunoprecipitation (co-IP) provided evidence that Serpina3c bound nuclear factor erythroid 2-related factor 2 (Nrf2) to regulate Hif1α. Nrf2 KD reduced Hif1α and Fasn expression, decreased lipid content, and reduced the extracellular acidification rate in Serpina3c KO adipocytes. Metabolomics revealed that lactic acid (LD) levels in eWAT were responsible for adipose-associated macrophage inflammation. In summary, Serpina3c inhibits the Hif1α-glycolysis pathway and reduces de novo lipogenesis and LD secretion in adipocytes by binding to Nrf2, thereby improving HFD-induced lipid metabolism disorders and alleviating adipose tissue macrophage inflammation.
Skip Nav Destination
Article navigation
Research Article|
December 18 2024
Serpina3c Deficiency Promotes Obesity-related Hypertriglyceridemia and Inflammation through Activation of the Hif1α-glycolysis Axis in Adipose Tissue
Zhenjun Ji;
Zhenjun Ji
Southeast University, Nanjing, China
Search for other works by this author on:
Shaofan Wang;
Shaofan Wang
Southeast University, nanjing, China
Search for other works by this author on:
Peng Zheng;
Peng Zheng
Southeast University, nanjing, China
Search for other works by this author on:
Mengchen Yang;
Mengchen Yang
Southeast University, nanjing, China
Search for other works by this author on:
Yongjun Li;
Yongjun Li
Southeast University, nanjing, China
Search for other works by this author on:
Genshan Ma;
Genshan Ma
Southeast University, nanjing, China
Search for other works by this author on:
Yuyu Yao
Southeast University, Nanjing, China
* Corresponding Author; email: [email protected]
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
October 14 2024
Revision Received:
December 11 2024
Accepted:
December 18 2024
Online ISSN: 1470-8736
Print ISSN: 0143-5221
Funding Group:
- Award Group:
- Funder(s):
- Award Id(s): 82370443
- Principal Award Recipient(s): YuyuYao
- Funder(s):
- Award Group:
- Funder(s):
- Award Id(s): BE2022852
- Principal Award Recipient(s): GenshanMa
- Funder(s):
- Award Group:
- Funder(s):
- Award Id(s): ZDXK202207
- Principal Award Recipient(s): GenshanMa
- Funder(s):
Copyright 2024 The Author(s)
2024
This is an Accepted Manuscript; not the final Version of Record. Archiving permitted only in line with the archiving policy of Portland Press Limited.
Clin Sci (Lond) (2024) CS20242610.
Article history
Received:
October 14 2024
Revision Received:
December 11 2024
Accepted:
December 18 2024
Citation
Jiaqi Guo, Zhenjun Ji, Yu Jiang, Ya Wu, Shaofan Wang, Peng Zheng, Mengchen Yang, Yongjun Li, Genshan Ma, Yuyu Yao; Serpina3c Deficiency Promotes Obesity-related Hypertriglyceridemia and Inflammation through Activation of the Hif1α-glycolysis Axis in Adipose Tissue. Clin Sci (Lond) 2024; CS20242610. doi: https://doi.org/10.1042/CS20242610
Download citation file:
336
Views
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |